Adaptive Biotechnologies
ADPT
$2.58
Share price
2.79%
Change (1 day)
-68.73%
Change (1 year)
Categories
Market capitalization of Adaptive Biotechnologies (ADPT)
Market cap: $0.37 Billion
As of April 2024 Adaptive Biotechnologies has a market cap of $0.37 Billion. This makes Adaptive Biotechnologies the world's 6297th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Adaptive Biotechnologies from 2019 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.37 B | -47.23% |
| 2023 | $0.70 B | -35.07% |
| 2022 | $1.09 B | -72.41% |
| 2021 | $3.96 B | -51.03% |
| 2020 | $8.08 B | 115.83% |
| 2019 | $3.74 B |
End of Day market cap according to different sources
On Apr 22nd, 2024 the market cap of Adaptive Biotechnologies was reported to be:
$0.36 Billion
$0.36 Billion
$0.36 Billion
$0.36 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 HCA Healthcare HCA | $84.48 B | 22,469.07% | 🇺🇸 USA |
 Premier PINC | $2.51 B | 573.13% | 🇺🇸 USA |
 Community Health Systems
CYH | $0.41 B | 9.90% | 🇺🇸 USA |
 Select Medical Holdings SEM | $3.61 B | 865.93% | 🇺🇸 USA |